Related Experiment Video
Updated: Apr 11, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.3K
Melatonin Treatment in Children with Developmental Disabilities
A J Schwichtenberg1, Beth A Malow2
1Department of Human Development and Family Studies, Department of Psychological Sciences, Department of Speech, Language, and Hearing Sciences, Purdue University, 1202 West State Street, West Lafayette, IN 47907-2055, USA.
Sleep Medicine Clinics
|June 10, 2015
Summary
Melatonin effectively reduced sleep onset latency in children with developmental disabilities. While side effects were mild and uncommon, more research is needed for specific conditions.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Developmental Disabilities Research
Background:
- Melatonin is frequently suggested for sleep issues in children with developmental disabilities.
- Limited research exists on melatonin's efficacy and safety in these specific pediatric populations.
Purpose of the Study:
- To review recent studies on the efficacy of melatonin for sleep problems in children with developmental disabilities.
- To assess the safety profile of melatonin in this patient group.
Main Methods:
- Systematic review of recent scientific literature on melatonin use in pediatric developmental disabilities.
- Analysis of studies focusing on sleep onset latency and reported side effects.
Main Results:
- Short-term melatonin trials showed significant reductions in sleep onset latency across most reviewed developmental disabilities.
- Tuberous sclerosis was a notable exception where efficacy was not consistently observed.
- Reported side effects were infrequent and generally mild.
Conclusions:
- Current evidence supports melatonin's potential efficacy for sleep onset latency in children with developmental disabilities.
- Further research with larger cohorts and disability-specific analyses is necessary.
- Findings encourage future trials investigating melatonin in diverse pediatric developmental disability populations.
Related Concept Videos
01:19Management of Insomnia
789
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
789
01:18Nightmares and Night Terrors
884
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
Nightmares...
884
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
914
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
914
01:15REM Sleep Behavior Disorder
2.6K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.6K
01:07Narcolepsy
797
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
797
01:27Insomnia
609
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
609